The controversy arose during a discussion of the national budget, where discrepancies between official Cabinet figures and statements made by the MHIF head were highlighted by lawmakers.
Budget discrepancies and drug procurement issues
The debate was triggered by MP Dastan Bekeshev, a member of the 'El Ümütü Ata-Jurt' group, who questioned why the MHIF budget for 2027 appears significantly lower than the 2026 allocation. In response, MHIF Director Azamat Mukanov explained that while the adjusted 2026 budget is set at 33.8 billion soms, the 2027 provision is 12 billion soms, noting that approved budgets are typically lower initially and increase throughout the year.
Bekeshev further challenged the fund's management regarding subsidized medicine. Although Mukanov stated that an 800 million som additional package is provided by the fund, Bekeshev pointed out that only 400 million soms have been utilized so far, raising concerns about citizens' access to essential drugs.
The head of the MHIF, looking us in the eyes, provides incorrect figures. Dastan Dalabaevich, you are simply being deceived. We see the data. Ministry of Health, please check this. He is voicing incorrect information.
MP Kamila Talieva, representing the 'El Ümütü Ata-Jurt' group, urged fellow lawmakers to scrutinize the accuracy of information provided by Cabinet members, emphasizing that the discrepancies between MHIF statements and Ministry of Health data must be addressed.










